SEC Form 4 · accession 0001209191-17-032134
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thierry B. Thaure
Director
Period of report
May 12, 2017
Accepted (ET)
May 12, 2017 · 6:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001625101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2017 | M | 10,000 | $2.67 | A | 10,000 | D | |
| Common Stock | May 12, 2017 | S | 5,000 | $23.90 | D | 5,000 | D | |
| Common Stock | May 12, 2017 | S | 5,000 | $24.90 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.67 | May 12, 2017 | M | 10,000 | D | — | Jun 1, 2020 | Common Stock | 10,000 | 50,655 | D |
Explanation of responses
- F1The shares subject to the option will vest in equal quarterly installments over a three year period commencing on June 1, 2015 and ending on March 1, 2018, subject to the Reporting Person's continued service through each vesting date.